HEADER TRANSFERASE/INHIBITOR 19-DEC-16 5UAB TITLE MET TYROSINE KINASE INHIBITION ENHANCES THE ANTITUMOR EFFICACY OF AN TITLE 2 HGF ANTIBODY COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1041-1378; COMPND 5 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 6 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PFASTBACHTB KEYWDS MET, TYROSINE KINASE, INHIBITOR, ANTITUMOR, TRANSFERASE-INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.D.HOFFMAN,J.D.LAWSON REVDAT 4 06-MAR-24 5UAB 1 REMARK REVDAT 3 22-NOV-17 5UAB 1 REMARK REVDAT 2 19-JUL-17 5UAB 1 JRNL REVDAT 1 31-MAY-17 5UAB 0 JRNL AUTH P.J.FARRELL,J.MATUSZKIEWICZ,D.BALAKRISHNA,S.PANDYA, JRNL AUTH 2 M.S.HIXON,R.KAMRAN,S.CHU,J.D.LAWSON,K.OKADA,A.HORI, JRNL AUTH 3 A.MIZUTANI,H.IWATA,R.DE JONG,B.HIBNER,P.VINCENT JRNL TITL MET TYROSINE KINASE INHIBITION ENHANCES THE ANTITUMOR JRNL TITL 2 EFFICACY OF AN HGF ANTIBODY. JRNL REF MOL. CANCER THER. V. 16 1269 2017 JRNL REFN ESSN 1538-8514 JRNL PMID 28341789 JRNL DOI 10.1158/1535-7163.MCT-16-0771 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 3 NUMBER OF REFLECTIONS : 23091 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1162 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1153 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 64.60 REMARK 3 BIN R VALUE (WORKING SET) : 0.2940 REMARK 3 BIN FREE R VALUE SET COUNT : 66 REMARK 3 BIN FREE R VALUE : 0.2980 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2302 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 158 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.91000 REMARK 3 B22 (A**2) : -1.93000 REMARK 3 B33 (A**2) : 3.84000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.168 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.149 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.109 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.364 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2399 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2299 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3252 ; 1.137 ; 1.969 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5289 ; 0.875 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 285 ; 5.255 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 100 ;33.567 ;23.400 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 405 ;11.166 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;15.773 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 361 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2663 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 552 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1030 A 1360 REMARK 3 ORIGIN FOR THE GROUP (A): -9.9642 0.5036 15.9769 REMARK 3 T TENSOR REMARK 3 T11: 0.1267 T22: 0.0934 REMARK 3 T33: 0.0123 T12: -0.0258 REMARK 3 T13: -0.0038 T23: -0.0247 REMARK 3 L TENSOR REMARK 3 L11: 1.9782 L22: 2.5735 REMARK 3 L33: 1.9836 L12: 0.4777 REMARK 3 L13: 0.3172 L23: -0.3194 REMARK 3 S TENSOR REMARK 3 S11: 0.0792 S12: -0.4211 S13: 0.1295 REMARK 3 S21: 0.5207 S22: -0.1195 S23: -0.0152 REMARK 3 S31: -0.2618 S32: -0.0011 S33: 0.0403 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5UAB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1000225566. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-MAY-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9-7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9764848 REMARK 200 MONOCHROMATOR : SI(111) AND SI(220) DOUBLE REMARK 200 CRYSTAL REMARK 200 OPTICS : MIRROR: RH COATED FLAT, TOROIDAL REMARK 200 FOCUSING REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24319 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.8 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 65.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.28200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16.% PEG MME 5000, 15.% ISOPROPANOL, REMARK 280 0.1M HEPES PH 7.8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.16650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.91050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.58350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.91050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.16650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.58350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1019 REMARK 465 ALA A 1020 REMARK 465 MET A 1021 REMARK 465 GLY A 1022 REMARK 465 SER A 1023 REMARK 465 GLN A 1024 REMARK 465 VAL A 1025 REMARK 465 GLN A 1026 REMARK 465 TYR A 1027 REMARK 465 PRO A 1028 REMARK 465 LEU A 1029 REMARK 465 LEU A 1035A REMARK 465 THR A 1035B REMARK 465 SER A 1035C REMARK 465 GLY A 1035D REMARK 465 ASP A 1035E REMARK 465 SER A 1035F REMARK 465 ASP A 1035G REMARK 465 ILE A 1035H REMARK 465 SER A 1035I REMARK 465 SER A 1035J REMARK 465 PRO A 1035K REMARK 465 LEU A 1035L REMARK 465 LEU A 1035M REMARK 465 GLN A 1035N REMARK 465 ASN A 1035O REMARK 465 THR A 1035P REMARK 465 VAL A 1035Q REMARK 465 HIS A 1035R REMARK 465 ILE A 1035S REMARK 465 ASP A 1035T REMARK 465 LEU A 1035U REMARK 465 SER A 1035V REMARK 465 ALA A 1035W REMARK 465 LEU A 1035X REMARK 465 LEU A 1098 REMARK 465 ASP A 1099 REMARK 465 ASN A 1100 REMARK 465 ASP A 1101 REMARK 465 GLY A 1102 REMARK 465 LYS A 1103 REMARK 465 LYS A 1104 REMARK 465 ILE A 1105 REMARK 465 ARG A 1114 REMARK 465 ILE A 1115 REMARK 465 THR A 1116 REMARK 465 ASP A 1117 REMARK 465 ILE A 1118 REMARK 465 GLY A 1119 REMARK 465 GLU A 1120 REMARK 465 ARG A 1148 REMARK 465 SER A 1149 REMARK 465 GLU A 1150 REMARK 465 GLY A 1151 REMARK 465 SER A 1152 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A1233 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A1203 -11.15 81.14 REMARK 500 ASP A1204 43.62 -152.43 REMARK 500 ALA A1221 -157.00 -126.91 REMARK 500 ASP A1286 -0.62 75.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 84M A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 1402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5UAD RELATED DB: PDB REMARK 900 RELATED ID: 5UAF RELATED DB: PDB DBREF 5UAB A 1024 1360 UNP P08581 MET_HUMAN 1041 1378 SEQADV 5UAB GLY A 1019 UNP P08581 EXPRESSION TAG SEQADV 5UAB ALA A 1020 UNP P08581 EXPRESSION TAG SEQADV 5UAB MET A 1021 UNP P08581 EXPRESSION TAG SEQADV 5UAB GLY A 1022 UNP P08581 EXPRESSION TAG SEQADV 5UAB SER A 1023 UNP P08581 EXPRESSION TAG SEQRES 1 A 343 GLY ALA MET GLY SER GLN VAL GLN TYR PRO LEU THR ASP SEQRES 2 A 343 MET SER PRO ILE LEU THR SER GLY ASP SER ASP ILE SER SEQRES 3 A 343 SER PRO LEU LEU GLN ASN THR VAL HIS ILE ASP LEU SER SEQRES 4 A 343 ALA LEU ASN PRO GLU LEU VAL GLN ALA VAL GLN HIS VAL SEQRES 5 A 343 VAL ILE GLY PRO SER SER LEU ILE VAL HIS PHE ASN GLU SEQRES 6 A 343 VAL ILE GLY ARG GLY HIS PHE GLY CYS VAL TYR HIS GLY SEQRES 7 A 343 THR LEU LEU ASP ASN ASP GLY LYS LYS ILE HIS CYS ALA SEQRES 8 A 343 VAL LYS SER LEU ASN ARG ILE THR ASP ILE GLY GLU VAL SEQRES 9 A 343 SER GLN PHE LEU THR GLU GLY ILE ILE MET LYS ASP PHE SEQRES 10 A 343 SER HIS PRO ASN VAL LEU SER LEU LEU GLY ILE CYS LEU SEQRES 11 A 343 ARG SER GLU GLY SER PRO LEU VAL VAL LEU PRO TYR MET SEQRES 12 A 343 LYS HIS GLY ASP LEU ARG ASN PHE ILE ARG ASN GLU THR SEQRES 13 A 343 HIS ASN PRO THR VAL LYS ASP LEU ILE GLY PHE GLY LEU SEQRES 14 A 343 GLN VAL ALA LYS GLY MET LYS TYR LEU ALA SER LYS LYS SEQRES 15 A 343 PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU SEQRES 16 A 343 ASP GLU LYS PHE THR VAL LYS VAL ALA ASP PHE GLY LEU SEQRES 17 A 343 ALA ARG ASP MET TYR ASP LYS GLU TYR TYR SER VAL HIS SEQRES 18 A 343 ASN LYS THR GLY ALA LYS LEU PRO VAL LYS TRP MET ALA SEQRES 19 A 343 LEU GLU SER LEU GLN THR GLN LYS PHE THR THR LYS SER SEQRES 20 A 343 ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU LEU MET SEQRES 21 A 343 THR ARG GLY ALA PRO PRO TYR PRO ASP VAL ASN THR PHE SEQRES 22 A 343 ASP ILE THR VAL TYR LEU LEU GLN GLY ARG ARG LEU LEU SEQRES 23 A 343 GLN PRO GLU TYR CYS PRO ASP PRO LEU TYR GLU VAL MET SEQRES 24 A 343 LEU LYS CYS TRP HIS PRO LYS ALA GLU MET ARG PRO SER SEQRES 25 A 343 PHE SER GLU LEU VAL SER ARG ILE SER ALA ILE PHE SER SEQRES 26 A 343 THR PHE ILE GLY GLU HIS TYR VAL HIS VAL ASN ALA THR SEQRES 27 A 343 TYR VAL ASN VAL LYS HET 84M A1401 25 HET GOL A1402 6 HET CL A1403 1 HETNAM 84M N-{6-[([1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-YL) HETNAM 2 84M SULFANYL]IMIDAZO[1,2-B]PYRIDAZIN-2- HETNAM 3 84M YL}CYCLOPROPANECARBOXAMIDE HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 84M C16 H13 N7 O S FORMUL 3 GOL C3 H8 O3 FORMUL 4 CL CL 1- FORMUL 5 HOH *158(H2 O) HELIX 1 AA1 PRO A 1060 VAL A 1066 1 7 HELIX 2 AA2 GLY A 1072 LEU A 1076 5 5 HELIX 3 AA3 SER A 1122 PHE A 1134 1 13 HELIX 4 AA4 ASP A 1164 ASN A 1171 1 8 HELIX 5 AA5 THR A 1177 LYS A 1198 1 22 HELIX 6 AA6 ALA A 1206 ARG A 1208 5 3 HELIX 7 AA7 PHE A 1223 ARG A 1227 5 5 HELIX 8 AA8 ASP A 1231 TYR A 1235 5 5 HELIX 9 AA9 PRO A 1246 MET A 1250 5 5 HELIX 10 AB1 ALA A 1251 GLN A 1258 1 8 HELIX 11 AB2 THR A 1261 THR A 1278 1 18 HELIX 12 AB3 ASP A 1291 LEU A 1297 1 7 HELIX 13 AB4 PRO A 1309 TRP A 1320 1 12 HELIX 14 AB5 LYS A 1323 ARG A 1327 5 5 HELIX 15 AB6 SER A 1329 THR A 1343 1 15 SHEET 1 AA1 5 ILE A1077 GLY A1087 0 SHEET 2 AA1 5 GLY A1090 THR A1096 -1 O VAL A1092 N GLY A1085 SHEET 3 AA1 5 CYS A1107 LEU A1112 -1 O VAL A1109 N TYR A1093 SHEET 4 AA1 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 AA1 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 AA2 2 CYS A1210 LEU A1212 0 SHEET 2 AA2 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 AA3 2 SER A1236 VAL A1237 0 SHEET 2 AA3 2 LYS A1244 LEU A1245 -1 O LEU A1245 N SER A1236 SITE 1 AC1 13 ILE A1084 ALA A1108 PRO A1158 TYR A1159 SITE 2 AC1 13 MET A1160 LYS A1161 GLY A1163 ARG A1208 SITE 3 AC1 13 MET A1211 ALA A1221 ASP A1222 ALA A1226 SITE 4 AC1 13 TYR A1230 SITE 1 AC2 5 PHE A1168 ASN A1175 PRO A1176 ASP A1180 SITE 2 AC2 5 HOH A1580 SITE 1 AC3 4 LYS A1179 GLY A1346 GLU A1347 HIS A1348 CRYST1 42.333 47.167 159.821 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023622 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021201 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006257 0.00000